Welcome to our dedicated page for AMN HEALTHCARE SERVICES SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMN HEALTHCARE SERVICES's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMN HEALTHCARE SERVICES's regulatory disclosures and financial reporting.
AMN Healthcare Services executive Mark Christopher Hagan, Chief Information and Digital officer, reported multiple equity compensation transactions on January 15, 2026. Several blocks of Restricted Stock Units (RSUs) vested and were converted into common stock, including 1,433, 2,248, and 6,632 shares of AMN common stock. To cover taxes, the company withheld 591, 926, and 2,622 shares at a price of $19.55 per share.
On the same date, Hagan received a new grant of 36,828 RSUs under the AMN Healthcare 2025 Equity Plan, each representing a right to one share of common stock. After these transactions, he directly owned 44,873 shares of AMN common stock and held 73,656 RSUs. The RSUs granted on January 15 of 2023, 2024, 2025, and 2026 all vest in three annual tranches tied to continued service.
AMN Healthcare Services CFO/COO Brian M. Scott reported equity compensation activity on January 15, 2026. He acquired 8,843 shares of common stock at $0 upon vesting of Restricted Stock Units and then had 3,592 shares of common stock withheld at $19.55 per share to cover taxes, leaving him with 13,093 shares of common stock held directly.
On the derivative side, 8,843 Restricted Stock Units were converted into common stock, after which he held 17,956 Restricted Stock Units from an award granted under the AMN Healthcare 2017 Equity Plan that vests over three years. He also received a new grant of 40,920 Restricted Stock Units under the AMN Healthcare 2025 Equity Plan, bringing his total Restricted Stock Units to 81,840, each representing a contingent right to one share of AMN common stock and vesting in three annual tranches.
AMN Healthcare Services, Inc. will present at the J.P. Morgan Healthcare Conference on January 14, 2026. The company has prepared a slide presentation for this event, which is attached as Exhibit 99.1 and will also be available through the Investor Relations section of its website at https://ir.amnhealthcare.com/.
The information related to this conference appearance is being furnished under Item 7.01 and is not deemed filed under securities laws, meaning it will only be incorporated into other documents by specific reference. The report is signed on behalf of the company by Chief Executive Officer Cary Grace.
AMN Healthcare Services Inc executive Brian M. Scott, the company's CFO/COO, reported the vesting of restricted stock units into 12,212 shares of common stock on December 15, 2025. These shares were acquired at $0 per share as the units converted.
On the same date, 4,370 shares were disposed of at $16.37 per share to cover tax obligations, leaving Scott with 7,842 common shares held directly. He also holds 24,797 restricted stock units granted on December 15, 2024 under the AMN Healthcare 2017 Equity Plan, which vest on the first, second and third anniversaries of the grant date, with each unit representing one share of AMN common stock and no expiration date.
AMN Healthcare Services, Inc. reported that its Board of Directors approved amended and restated by-laws, effective immediately on December 11, 2025. The changes are designed to align its governance rules with current Delaware law and to tighten and clarify procedures around how stockholders call special meetings and bring business before meetings.
The updated by-laws refine the information and disclosure that stockholders must provide when nominating directors or submitting proposals, and they clarify the authority of the Board and the meeting chair to manage conduct at stockholder meetings. They also require director candidates to be available for interviews with Board members about their qualifications, while making additional ministerial and conforming updates.
AMN Healthcare Services (AMN) received a Schedule 13G from investors affiliated with Millennium. Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 2,446,024 shares of common stock, representing 6.4% of the class, with shared voting and dispositive power over those shares and no sole power. Integrated Core Strategies (US) LLC reported beneficial ownership of 2,425,686 shares, representing 6.3% of the class, also with shared voting and dispositive power and no sole power.
The filers certified the securities were not acquired and are not held for the purpose of changing or influencing control of AMN. The filing relates to AMN’s common stock, par value $0.01 per share, and lists a Date of Event of 11/04/2025.
AMN Healthcare Services (AMN) filed its Q3 2025 report, showing revenue of $634.5 million, down from $687.5 million a year ago. Net income rose to $29.3 million from $7.0 million, with diluted EPS of $0.76 versus $0.18.
Year to date, revenue was $1,982.2 million versus $2,249.1 million, and the company reported a net loss of $88.0 million, primarily reflecting a non-cash goodwill impairment of $109.5 million and a $18.3 million long‑lived asset impairment recorded earlier in the year. Q3 included a $39.2 million gain on the sale of the Smart Square scheduling software, for which AMN received $65.3 million in cash and a $10.0 million 9.000% promissory note due January 1, 2027.
Operating cash flow reached $193.9 million for the nine months. Cash and cash equivalents were $52.6 million, and total stockholders’ equity was $644.4 million at September 30, 2025. Segment Q3 revenue: Nurse & Allied $361.5 million, Physician & Leadership $178.2 million, Technology & Workforce $94.8 million.
Subsequent events: On October 6, 2025, AMN issued $400.0 million of 6.500% senior notes due 2031 and amended its credit facility (maturity extended to October 6, 2030; revolving commitments set at $450.0 million; leverage covenant updated). On October 22, 2025, it redeemed the $500.0 million 2027 notes using note proceeds, revolver borrowings, and operating cash.
AMN Healthcare Services, Inc. furnished an update on its business by reporting results for the fiscal quarter ended September 30, 2025. The company provided the details in a press release attached as Exhibit 99.1.
The information related to these quarterly results is furnished under Item 2.02 and, as stated, is not deemed “filed” under Section 18 of the Exchange Act. AMN’s common stock trades on the NYSE under the symbol AMN.
AMN Healthcare Services (AMN): Schedule 13G/A filed by FMR LLC
FMR LLC and Abigail P. Johnson filed Amendment No. 1 to their Schedule 13G for AMN Healthcare Services. The filing reports beneficial ownership of 4,409.09 shares of common stock, representing 0.0% of the class as of 09/30/2025. FMR reports 2,154.00 shares with sole voting power and 4,409.09 shares with sole dispositive power, with 0 shared voting or dispositive power.
The filing indicates ownership of five percent or less of the class. It also states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. One or more other persons may have the right to receive dividends or sale proceeds, with no single such interest exceeding five percent.
AMN Healthcare (AMN) insider transaction: On 10/15/2025, an officer (Chief Information and Digital) reported the vesting of 9,330 shares of common stock upon Restricted Stock Units (RSUs) settlement. The filer disposed of 3,339 shares at $20.69 to cover taxes. Following these transactions, the filer beneficially owned 38,699 shares directly. RSUs remaining after the event totaled 9,331.
The RSUs were granted on 10/15/2024 under the AMN Healthcare 2017 Equity Plan and vest in two tranches on the first and second anniversaries of the grant date, subject to credited service.